HomeNews

News
New Phase 3 Trial Data Confirm the Uniquely High Efficacy and Good Safety Profile of the R21/Matrix-M Malaria Vaccine in African Children

New phase 3 trial data confirm the uniquely high efficacy and good safety profile of the R21/Matrix-M malaria vaccine in African children

Global health
Health
Malaria
Research
Vaccines
FCDO Minister meets with University of Oxford’s vaccine researchers

FCDO Minister meets with University of Oxford’s vaccine researchers

COVID-19 vaccine
Funding
Global health
Malaria
Research
Vaccines
Lymph node research pioneers’ new approach to vaccine design for the most vulnerable

Lymph node research pioneers’ new approach to vaccine design for the most vulnerable

COVID-19 vaccine
Global health
Health
Vaccines
Long function machine for the Novel inhaled TB vaccine

Novel inhaled TB vaccine

Global health
Research
Vaccines
First-in-human vaccine trial for deadly Nipah virus launched

First-in-human vaccine trial for deadly Nipah virus launched

Global health
Vaccines
pipette and test tubes

VALIDATE network receives Medical Research Council grant

Funding
Global health
Health
Medical Sciences
Research
A panorama view of the center of Oxford skyline.

Professor Alan Bernstein appointed as new University of Oxford Director of Global Health

Global health
Health
Medical Sciences
Society
University
Peter Horby

ALERRT epidemic research network launched in sub-Saharan Africa

Global health
Health
Research
Science

Pages